Achieve Life Sciences (ACHV) Prepaid Assets (2010 - 2026)
Achieve Life Sciences (ACHV) recorded quarterly Prepaid Assets of $1.7 million in Q1 2026, down 49.36% on a QoQ basis from $3.3 million in Q4 2025, and down 5.01% year-over-year from $1.8 million in Q1 2025.
Achieve Life Sciences (ACHV) Prepaid Assets (2010 - 2026) Analysis & Trends
Achieve Life Sciences has disclosed Prepaid Assets across 17 years of filings, most recently posting $1.7 million for Q1 2026.
- Quarterly Prepaid Assets fell 5.01% year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 million (down 5.01% YoY) and the FY2025 annual result came in at $3.3 million, up 56.24% from the prior year.
- Prepaid Assets slipped to $1.7 million in Q1 2026, from $3.3 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $3.3 million in Q4 2025 and troughed at $958000.0 in Q2 2023.
- A 5-year average of $1.8 million and a median of $1.7 million in 2026 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2022 — Prepaid Assets surged 238.84% — and 2023, when it tumbled 46.01%.
- Tracing ACHV's Prepaid Assets over 5 years: stood at $2.5 million in 2022, then slumped by 46.01% to $1.3 million in 2023, then soared by 59.02% to $2.1 million in 2024, then jumped by 56.24% to $3.3 million in 2025, then sank by 49.36% to $1.7 million in 2026.
- Business Quant data shows ACHV's Prepaid Assets at $1.7 million in Q1 2026, $3.3 million in Q4 2025, and $1.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Achieve Life Sciences | 93.71 Mn | 63.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.67 Mn |
| Dec 31, 2025 | 3.29 Mn |
| Sep 30, 2025 | 1.94 Mn |
| Jun 30, 2025 | 1.51 Mn |
| Mar 31, 2025 | 1.76 Mn |
| Dec 31, 2024 | 2.11 Mn |
| Sep 30, 2024 | 2.62 Mn |
| Jun 30, 2024 | 1.21 Mn |
| Mar 31, 2024 | 1.31 Mn |
| Dec 31, 2023 | 1.33 Mn |
| Sep 30, 2023 | 1.90 Mn |
| Jun 30, 2023 | 958,000.00 |
| Mar 31, 2023 | 1.62 Mn |
| Dec 31, 2022 | 2.45 Mn |
| Sep 30, 2022 | 2.62 Mn |
| Jun 30, 2022 | 1.46 Mn |
| Mar 31, 2022 | 1.36 Mn |
| Dec 31, 2021 | 1.42 Mn |
| Sep 30, 2021 | 1.27 Mn |
| Jun 30, 2021 | 430,000.00 |